Dr. Gilbert Tang/X
Nov 13, 2025, 01:15
Dr. Gilbert Tang Shares NEJM Late-Breaker: 7-Year Outcomes Reinforce TAVR as a Durable Option for Low-Risk Aortic Stenosis
Dr. Gilbert Tang, Vice Chair of Innovation, Cardiovascular Surgery Surgical and Academic Director at Mount Sinai Health System, shared a post on X:
“TCT2025 Late breaker PARTNER 3 Low Risk 7 Year Sapien3 TAVR vs SAVR showed no significant differences in composite endpoint, all-cause mortality, CV mortality, and low reintervention rates in both arms. Clinical valve thrombosis 2.8% TAVR vs 0.5% SAVR but similar BVF (valve failure) and reintervention.
Paper now online The New England Journal of Medicine (NEJM)
and can download here.
Nice TCTMD article.”
Stay updated with Hemostasis Today.
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’
-
Jul 7, 2026, 20:59William Aird: An Unlucky Turn Into the Renal Artery
-
Jul 7, 2026, 20:58Chokri Ben Lamine: The Two-Hit Model of TRALI
-
Jul 7, 2026, 20:57New Issue of Blood Out Now – Blood Journals Portfolio
-
Jul 7, 2026, 20:56Priyadarshini Ramakrishnan: Schistocytes – The Most “Misleading Heroes” in a Peripheral Smear